INVO Bioscience, Inc. (INVO)
NASDAQ: INVO · Real-Time Price · USD
0.700
+0.025 (3.70%)
At close: Oct 4, 2024, 4:00 PM
0.720
+0.020 (2.86%)
After-hours: Oct 4, 2024, 5:28 PM EDT
INVO Bioscience Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 5.77 | 3.02 | 0.82 | 4.16 | 1.04 | 1.48 | Upgrade
|
| Revenue Growth (YoY) | 390.03% | 267.38% | -80.24% | 301.06% | -29.92% | 199.41% | Upgrade
|
| Cost of Revenue | 3.18 | 1.93 | 0.85 | 0.13 | 0.08 | 0.13 | Upgrade
|
| Gross Profit | 2.59 | 1.09 | -0.03 | 4.03 | 0.96 | 1.35 | Upgrade
|
| Selling, General & Admin | 7.2 | 7.49 | 9.98 | 9.02 | 6.07 | 3.13 | Upgrade
|
| Research & Development | 0.01 | 0.17 | 0.54 | 0.22 | 0.4 | - | Upgrade
|
| Operating Expenses | 7.83 | 7.85 | 10.6 | 9.25 | 6.47 | 3.13 | Upgrade
|
| Operating Income | -5.24 | -6.77 | -10.63 | -5.22 | -5.51 | -1.79 | Upgrade
|
| Interest Expense | -1.09 | -0.93 | -0.06 | -1.27 | -2.84 | -0.39 | Upgrade
|
| Interest & Investment Income | - | - | 0 | 0 | 0 | 0.01 | Upgrade
|
| Earnings From Equity Investments | -0.02 | -0.06 | -0.2 | -0.33 | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | -0 | -0 | -0 | -0 | - | - | Upgrade
|
| EBT Excluding Unusual Items | -6.35 | -7.75 | -10.89 | -6.81 | -8.35 | -2.17 | Upgrade
|
| Gain (Loss) on Sale of Investments | -0.09 | -0.09 | - | - | - | - | Upgrade
|
| Other Unusual Items | -0.11 | -0.16 | - | 0.16 | - | - | Upgrade
|
| Pretax Income | -7.06 | -8.01 | -10.89 | -6.65 | -8.35 | -2.17 | Upgrade
|
| Income Tax Expense | 0.03 | 0.03 | 0 | 0 | 0 | 0 | Upgrade
|
| Net Income | -7.08 | -8.03 | -10.89 | -6.65 | -8.35 | -2.17 | Upgrade
|
| Net Income to Common | -7.08 | -8.03 | -10.89 | -6.65 | -8.35 | -2.17 | Upgrade
|
| Shares Outstanding (Basic) | 3 | 2 | 1 | 1 | 0 | 0 | Upgrade
|
| Shares Outstanding (Diluted) | 3 | 2 | 1 | 1 | 0 | 0 | Upgrade
|
| Shares Change (YoY) | 329.85% | 158.35% | 14.02% | 93.68% | 13.08% | 5.45% | Upgrade
|
| EPS (Basic) | -2.56 | -5.13 | -17.97 | -12.52 | -30.41 | -8.93 | Upgrade
|
| EPS (Diluted) | -2.56 | -5.13 | -17.97 | -12.60 | -30.41 | -9.00 | Upgrade
|
| Free Cash Flow | -3.97 | -5.2 | -6.61 | -6.45 | -4.82 | 1.31 | Upgrade
|
| Free Cash Flow Per Share | -1.44 | -3.32 | -10.91 | -12.12 | -17.58 | 5.38 | Upgrade
|
| Gross Margin | 44.89% | 35.96% | -3.48% | 96.96% | 92.38% | 90.97% | Upgrade
|
| Operating Margin | -90.89% | -224.04% | -1292.45% | -125.39% | -531.67% | -120.80% | Upgrade
|
| Profit Margin | -122.80% | -266.00% | -1324.81% | -159.97% | -804.73% | -146.43% | Upgrade
|
| Free Cash Flow Margin | -68.75% | -172.15% | -804.44% | -154.94% | -465.10% | 88.21% | Upgrade
|
| EBITDA | -4.62 | -6.57 | -10.55 | -5.19 | -5.5 | -1.78 | Upgrade
|
| EBITDA Margin | -80.16% | -217.38% | - | -124.73% | - | -120.07% | Upgrade
|
| D&A For EBITDA | 0.62 | 0.2 | 0.08 | 0.03 | 0.01 | 0.01 | Upgrade
|
| EBIT | -5.24 | -6.77 | -10.63 | -5.22 | -5.51 | -1.79 | Upgrade
|
| EBIT Margin | -90.89% | -224.04% | - | -125.39% | - | -120.80% | Upgrade
|
| Revenue as Reported | 5.77 | 3.02 | 0.82 | 4.16 | 1.04 | 1.48 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.